Esophageal adenoma-carcinoma and Barrettis esophagus. Gastric adenocarcinoma and Helicobacter pylori;Adenocarcinoma esofágico y esófago de barrett. Adenocarcinoma gástrico y helicobacter pylori

Gastroenterologia y Hepatologia

Volumn 31, Issue SUPPL.4, 2013, Pages 66-69

  Garcia, Montserrat Andreu ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

Barrett's esophagus; Esophageal adenocarcinoma; Esophageal cancer; Gastric adenocarcinoma; Gastric cancer; Helicobacter pylori; MALT lymphoma

Indexed keywords

PROTON PUMP INHIBITOR;

ARTICLE; BARRETT ESOPHAGUS; CANCER PREVENTION; CANCER RISK; CANCER THERAPY; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HELICOBACTER PYLORI; HUMAN; MARGINAL ZONE LYMPHOMA; NONHUMAN; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; STOMACH ADENOCARCINOMA; STOMACH CANCER; ADENOCARCINOMA; ESOPHAGUS TUMOR; HELICOBACTER INFECTION; STOMACH TUMOR;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH NEOPLASMS;

EID: 84878216761     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/S0210-5705(08)76633-0     Document Type: Article

References (21)

1. Daly JM, Fry WA, Little AG, Winchester DP, McKee RF, Stewart AK, et al. Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg. 2000;190:562-72.
2. Sampliner R. Adenocarcinoma of the esophagus and gastric cardia: Is there progress in the face of increasing cancer incidence? Ann Intern Med. 1999;130:67-9.
3. Spechler SJ. Intestinal metaplasia at the gastroesophageal junction. Gastroenterology. 2004;126:567-75.
4. Murray L, Watson P, Johnston B, Sloan J, Mohan I, Mainie L, et al. Risk of adenocarcinoma in Barrett's oesophagus: population based study. BMJ. 2003;327:534-5.
5. Wang KK, Sampliner RE. Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol. 2008;103:788-97.
6. Wolfsen HC, Crook JE, Krishna M, Achem SR, Devault KR, Bouras EP, et al. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's esophagus. Gastroenterology. 2008;135:24-31.
7. Cooper GS, Kou TD, Chak A. Impact of previous Diagnoses of Barrett's esophagus and GERD and prior endoscopy on outcome from esophageal adenocarcinoma: A population-based analysis. Gastroenterology. 2008;134:A377.
8. Cooper GS, Kou TD, Chak A. Lack of temporal changes in diagnosis of Barrett esophagus and prior endoscopy in patients with esophageal adenocarcinoma. Gastroenterology. 2008;134: A377.
9. Ouatu-Lascar R, Fitzgerald RC, Triadafi Lopoulos G. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology. 1999;117:327-35.
10. Peters FT, Ganesh S, Kuipers EJ, SluiterWJ, Karrenbeld A, De Jager-Krikken A, et al. Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus. Scand J Gastroenterol. 2000;35:1238-44.
11. El-Serag HB, Wieman M, Richardson P. The use of acid-decreasing medication in veteran patients with gastro-oesophageal reflux disorder with and without Barrett's oesophagus. Aliment Pharmacol Ther. 2008;27:1293-9.
12. Wang VS, Hornik JL, Sepulveda JA, Poneros JM. Low rate of invasive adenocarcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology. 2008;134:A379.
13. Piraka CR, Elmunzer BJ, Kwon RS, Rubenstein JH. Invasive cancer in endoscopic mucosal resection specimens of non-nodular Barrett's esophagus: implications for ablative therapy. Gastroenterology. 2008;134:A397.
14. Konda VJ, Chennat JS, Ross AS, Lin SP, Cislo BM, Steans L, et al. Low rate of invasive cancer in patients undergoingmucosectomy for Barrett's esophagus (BE) an high grade dysplasia (HGD) or intramucosal carcinoma (IMC). Gastroenterology. 2008;134:A397.
15. Konda VJ, Ross AS, Ferguson MK, Hart JA, Lin S, Naylor K. Is the risk of concomitant invasive esophageal cancer in highgrade dysplasia in Barrett's esophagus overestimated? Clin Gastroenterol Hepatol. 2008;6:159-64.
16. Wolfsen HC, Crook JE, Krishna M, Achem SR, Devault KR, Bouras EP. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's esophagus. Gastroenterology. 2008;135:297-9.
17. Fuchs C, Mayer R. Gastric carcinoma. N Engl J Med. 1995;333:32-41.
18. Kato M, Asaka M, Ono S, Nakagawa M, Nakagawa S, Shimizu Y, et al. Eradication of Helicobacter pylori for primary gastric cancer and secondary gastric cancer after endoscopic mucosal resection. J Gastroenterol. 2007;42 Suppl 17:16-20.
19. Fukase K, Kato M, Kikuchi S, Asaka M. Eradication of Helicobacter pylori for the incidence of metachronous gastric cancer after endoscopic resection. Gastroenterology. 2008;134: A148.
20. Capelle LG, Vries AC, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. High adenocarcinoma risk after diagnosis og gastric MALT lymphoma: a long-term national study. Gastroenterology. 2008;134:A12.
21. Rabenstein T, May A, Gossner L, Manner H, Pech O, Vieth M, et al. Invisible gastric carcinoma detected by random biopsy ("biopsy gastric cancer"): long-term results after photodynamic therapy. Gastroenterology. 2008;134.